Current status of HIV/AIDS in Cameroon: How effective are control strategies?

International Journal of Environmental Research and Public Health

Volumn 5, Issue 5, 2008, Pages 378-383

  Mbanya, Dora ^a   Sama, Martyn ^b   Tchounwou, Paul ^c  

^a UNIVERSITY OF YAOUNDÉ I   (Cameroon)

^b Tropical Medicine Research Center   (Cameroon)

^c JACKSON STATE UNIVERSITY   (United States)

Author keywords

AIDS; Cameroon; HIV; Strategies

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; CAMEROON; CHILD; CONFERENCE PAPER; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; DISEASE CONTROL; FEMALE; GENETIC VARIABILITY; GOVERNMENT; GROUPS BY AGE; HEALTH CARE; HEALTH CARE PLANNING; HEALTH PROGRAM; HEALTH SURVEY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; ORPHANAGE; PANDEMIC; TEACHER; TUBERCULOSIS;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 58849161278     PISSN: None     EISSN: 16604601     Source Type: Journal    
DOI: 10.3390/ijerph5050378     Document Type: Conference Paper

References (23)

1. 2008 Report on the global HIV/AIDS epidemic. UNAIDS/WHO: Geneva, Switzerland, 2008.
2. 2007 Report on the global HIV/AIDS epidemic. UNAIDS/WHO: Geneva, Switzerland, 2007.
3. Fonjungo, P.; Mpoudi, E. N.; Torimiro, J. N.; Alemnji, G. A.; Eno, T.; Lyonga, J.; Nkengasong, J. N.; Lal, R. B.; Rayfield, M.; Kalish, L; Folks, T. M.; Pieniazek, D.: Human immunodeficiency virus type 1 group M protease in Cameroon: genetic diversity and protease inhibitor mutational features. J. Clin. Microbiol. 2002, 40, 837-845.
4. Ndembi, N.; Takehisa, J.; Zekeng, L.; Kobayashi, E.; Ngansop, C.; Songok, E. M.; Kageyama, S.; Takemura, T.; Ido, E.; Hayami, M; Kaptue, L.; Ichimura, H.: Genetic diversity of HIV type 1 in rural eastern Cameroon. J. Acquir. Immune. Defic. Syndr. 2004, 37, 1641-1650.
5. Ndongmo, C. B.; Pieniazek, D.; Holberg-Petersen, M.; Holm-Hansen, C.; Zekeng, L.; Jeansson, L.; Kaptue, L.; Kalish, M. L. HIV genetic diversity in Cameroon: possible public health importance. AIDS Res. Hum. Retrovir. 2006, 22, 812-816.
6. Koizumi, Y.; Ndembi, N.; Miyashita, M.; Lwembe, R.; Kageyama, S.; Mbanya, D.; Kaptue, L.; Numazaki, K.; Fujiyama, Y.; Ichimura, H. Emergence of antiretroviral therapy resistance-associated primary mutations among drug-naive HIV-1-infected individuals in rural Western Cameroon. J. Acquir. Immune. Defic. Syndr. 2006, 43, 15-22.
7. Ndembi, N.; Abraha, A.; Pilch, H.; Ichimura, H.; Mbanya, D.; Kaptue, L.; Salata, R.; Arts, E.J. Molecular characterization of HIV-1 and HIV-2 in Yaoundé, Cameroon: Evidence of major drug resistance mutations in newly diagnosed patients infected with subtypes other than subtype B. J. Clin. Microbiol. 2008, 46, 177-184.
8. Vanden Haesevelde, M.; Decourt, J. L.; De Leys, R. J.; Vanderborght, B.; van der Groen, G.; van Heuverswijn, H.; Saman E.: Genomic cloning and complete sequence analysis of a highly divergent African human immunodeficiency isolate. J. Virol. 1994, 68, 1586-1596.
9. Nkengasong, J. N.; Peeters, M.; vanden Haesevelde, M.; Musi, S. S.; Willems, B.; Ndumbe, P. M.; Delaporte, E.; Perret, J. L.; Piot, P.; van den Groen G. Antigenic evidence of the presence of the abberant HIV-1 ANT 70 virus in Cameroon and Gabon. AIDS 1993, 7, 1536-1538.
10. Simon, F.; Mauclère, P.; Roques, P.; Loussert-Ajaka, I.; Müller-Trutwin, M. C.; Saragosti, S.; Georges-Courbot, M.C.; Barré-Sinoussi, F.; Brun-Vézinet, F. Identification of a new Human Immunodeficiency Virus type 1 Distinct from Group and Group O. Nature Med. 1998, 4, 1032-1037.
11. Damond, F.; Worobey, M.; Campa, P.; Farfara, I.; Colin, G.; Matheron, S.; Brun-Vezinet, F.; Robertson, R.I.; Simon, F. Identification of a highly divergent HIV-2 and proposal for a change in HIV-2 classification. AIDS Res. Human. Retrovir. 2004, 20, 666-672.
12. DeCock, K. M.; Adjorlolo, G.; Ekpini, E.; Sibailly, T.; Kouado, J.; Maran, M.; Brattegaard, K.; Vetter, K. M.; Doorly, R.; Gayle, H. D. Epidemiology and transmission of HIV-2: Why there is no HIV-2 pandemic. JAMA 1993, 270, 2083-2086.
13. Ministère de la Santé Publique (Cadre conceptuel du DIS viable), 2002.
14. Mbopi Kéou, F. X.; Mpoudi-Ngollé, E.; Nkengasong, J.; Zekeng, L.; Mbanya, D.; Affana, G.; Mauclère, P.; Monny Lobé, M.; Tapko, J. B.; Ndumbe, P.: Trends of AIDS epidemic in Cameroon, 1986 through 1995. J. Acq. Immuno. Defic. Syndr. Hum. Retrovir. 1998, 18, 89-91.
15. Garcia-Calleja, J. M.; Mvondo, J. L.; Sam Abbenyi, S.; Zekeng, L.; Loius, J. P.; Trebucq, A.; Kaptue, L. Profil de l'épidémie VIH/SIDA au Cameroun. Bull. Liais. Doc. OCEAC 1992, 99, 31-33.
16. Garcia-Calleja, J.M.; Abbenyi, S. Review of HIV prevalence studies in Cameroon. AIDS Inform. Bull. 1993, 1, 5-6.
17. Sentinel Surveillance of the Ministry of Public Health, Cameroon, 2000.
18. Institut National de la Statistique Enquête Demographique et de Santé Cameroun 2004. http://www.measuredhs.com/countries/, accessed April 15, 2008.
19. National AIDS Control Committee's Annual Reports, Cameroon, 2005.
20. Iliff, P. J.; Piwoz, E. G.; Tavengwa, N. V.; Zunguza, C. D.; Marinda, E. T.; Nathoo, K.J.; Moulton, L.H.; Ward, B.J.; Humphrey, J.H.; ZVITAMBO study group. Early exclusive breastfeeding reduces the risk of postnatal HIV-1 transmission and increases HIV-free survival. AIDS 2005, 19, 699-708.
21. Kouam, L.; Nsangou, I.; Mbanya, D.; Nkam, M.; Kongnyuy, E. J.; Ngassa, P.; Tebeu, P. M.; Elobe, N.; Kamgaing, N. G.; Zekeng, L; Doh A. S. Prevention of mother-to-child transmission of HIV in Cameroon: experiences from the University Teaching Hospital in Yaounde (Cameroon). Zentralbl. Gynakol. 2006, 128, 82-86.
22. Musoko, J. J.; Macauley, I. B.; Zoungkanyi, A. B.; Assumpta Bella; Koulla-Shiro, S. Human Immunodeficiency Virus infection and associated factors among specific population subgroups in Cameroon. AIDS Behav. 2007, 10.1007/s10461-007, 9294-9298.
23. Comité National de Lutte contre le SIDA (Groupe Technique Central): Rapport annuel d'activités du Programme National de Lutte contre le SIDA, 2007; Yaoundé, Mars 2008.